Pfizer Inc Stock Analysis
PFE Stock | USD 27.75 0.03 0.11% |
Pfizer Inc is undervalued with Real Value of 33.17 and Target Price of 38.67. The main objective of Pfizer stock analysis is to determine its intrinsic value, which is an estimate of what Pfizer Inc is worth, separate from its market price. There are two main types of Pfizer's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Pfizer's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Pfizer's stock to identify patterns and trends that may indicate its future price movements.
The Pfizer stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Pfizer is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Pfizer Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pfizer's ongoing operational relationships across important fundamental and technical indicators.
Pfizer |
Pfizer Stock Analysis Notes
About 70.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.77. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pfizer Inc has Price/Earnings To Growth (PEG) ratio of 0.28. The entity last dividend was issued on the 25th of January 2024. The firm had 1054:1000 split on the 17th of November 2020. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 79000 people. To find out more about Pfizer Inc contact DVM DVM at 212 733 2323 or learn more at https://www.pfizer.com.Pfizer Quarterly Total Revenue |
|
Pfizer Inc Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Pfizer's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Pfizer Inc generated a negative expected return over the last 90 days | |
About 70.0% of the company shares are owned by institutional investors | |
On 1st of March 2024 Pfizer paid $ 0.42 per share dividend to its current shareholders | |
Latest headline from finance.yahoo.com: Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023 |
Pfizer Inc Upcoming and Recent Events
Earnings reports are used by Pfizer to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pfizer previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of May 2024 Upcoming Quarterly Report | View | |
6th of August 2024 Next Financial Report | View | |
31st of March 2024 Next Fiscal Quarter End | View | |
4th of February 2025 Next Fiscal Year End | View | |
31st of December 2023 Last Quarter Report | View | |
31st of December 2023 Last Financial Announcement | View |
Pfizer Largest EPS Surprises
Earnings surprises can significantly impact Pfizer's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
1999-07-19 | 1999-06-30 | 0.17 | 0.19 | 0.02 | 11 | ||
1998-10-13 | 1998-09-30 | 0.19 | 0.17 | -0.02 | 10 | ||
1998-07-09 | 1998-06-30 | 0.15 | 0.17 | 0.02 | 13 |
Pfizer Thematic Classifications
In addition to having Pfizer stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Robots And DronesCross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions |
Pfizer Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer Inc backward and forwards among themselves. Pfizer's institutional investor refers to the entity that pools money to purchase Pfizer's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | State Farm Mutual Automobile Ins Co | 2023-12-31 | 54.5 M | Legal & General Group Plc | 2023-12-31 | 49.6 M | Goldman Sachs Group Inc | 2023-12-31 | 48.1 M | Bank Of America Corp | 2023-12-31 | 47.9 M | Bank Of New York Mellon Corp | 2023-12-31 | 44.1 M | Amundi | 2023-12-31 | 42.6 M | Jpmorgan Chase & Co | 2023-12-31 | 42.4 M | Dimensional Fund Advisors, Inc. | 2023-12-31 | 42 M | Deutsche Bank Ag | 2023-12-31 | 40.2 M | Vanguard Group Inc | 2023-12-31 | 506.5 M | Blackrock Inc | 2023-12-31 | 432.5 M |
Pfizer Market Capitalization
The company currently falls under 'Mega-Cap' category with a total capitalization of 157.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Pfizer Profitablity
Pfizer's profitability indicators refer to fundamental financial ratios that showcase Pfizer's ability to generate income relative to its revenue or operating costs. If, let's say, Pfizer is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pfizer's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pfizer's profitability requires more research than a typical breakdown of Pfizer's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.04 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.5) %, which entails that for every $100 of revenue, it lost $0.5. Last Reported | Projected for 2024 | ||
Return On Capital Employed | 0.02 | 0.02 | |
Return On Assets | 0.01 | 0.01 | |
Return On Equity | 0.02 | 0.02 |
Management Efficiency
Pfizer Inc has Return on Asset of 0.0155 % which means that on every $100 spent on assets, it made $0.0155 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0235 %, implying that it generated $0.0235 on every 100 dollars invested. Pfizer's management efficiency ratios could be used to measure how well Pfizer manages its routine affairs as well as how well it operates its assets and liabilities. As of March 29, 2024, Return On Capital Employed is expected to decline to 0.02. In addition to that, Return On Assets is expected to decline to 0.01. At present, Pfizer's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 9.7 B, whereas Total Current Assets are forecasted to decline to about 32.2 B.Last Reported | Projected for 2024 | ||
Price Book Value Ratio | 1.83 | 1.73 | |
Enterprise Value Multiple | 22.29 | 14.99 | |
Price Fair Value | 1.83 | 1.73 |
The analysis of Pfizer's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Pfizer's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Pfizer Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0605 | Forward Dividend Yield 0.0605 | Forward Dividend Rate 1.68 | Beta 0.557 |
Technical Drivers
As of the 29th of March, Pfizer holds the Risk Adjusted Performance of 0.0046, variance of 1.89, and Coefficient Of Variation of (42,006). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Pfizer Inc, which can be compared to its competitors. Please check Pfizer Inc standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 27.75 per share. Given that Pfizer has information ratio of (0.10), we recommend you to check out Pfizer Inc's recent market performance to make sure the company can sustain itself at a future point.Pfizer Inc Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pfizer middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pfizer Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Pfizer Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pfizer insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pfizer's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pfizer insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
John Young over six months ago Acquisition by John Young of tradable shares of Pfizer subject to Rule 16b-3 |
Pfizer Outstanding Bonds
Pfizer issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pfizer Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pfizer bonds can be classified according to their maturity, which is the date when Pfizer Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
PFIZER INC 4125 Corp BondUS717081ED10 | View | |
PFIZER INC 4 Corp BondUS717081EC37 | View | |
PFIZER INC 3 Corp BondUS717081EA70 | View | |
PFIZER INC 34 Corp BondUS717081DM28 | View | |
PFIZER INC 44 Corp BondUS717081DK61 | View | |
PFIZER INC 275 Corp BondUS717081DV27 | View | |
US717081DT70 Corp BondUS717081DT70 | View | |
PFIZER INC Corp BondUS717081EZ22 | View |
Pfizer Predictive Daily Indicators
Pfizer intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pfizer stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 575327.0 | |||
Daily Balance Of Power | (0.07) | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 27.92 | |||
Day Typical Price | 27.86 | |||
Price Action Indicator | (0.19) | |||
Period Momentum Indicator | (0.03) |
Pfizer Corporate Filings
28th of March 2024 Other Reports | ViewVerify | |
F3 | 22nd of March 2024 An amendment to the original Schedule 13D filing | ViewVerify |
F3 | 19th of March 2024 An amendment to the original Schedule 13D filing | ViewVerify |
F4 | 18th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 15th of March 2024 An amended filing to the original Schedule 13G | ViewVerify |
14th of March 2024 Other Reports | ViewVerify | |
F4 | 5th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 1st of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Pfizer Forecast Models
Pfizer's time-series forecasting models are one of many Pfizer's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Pfizer Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Pfizer prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pfizer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pfizer. By using and applying Pfizer Stock analysis, traders can create a robust methodology for identifying Pfizer entry and exit points for their positions.
Last Reported | Projected for 2024 | ||
Pretax Profit Margin | 0.02 | 0.02 | |
Operating Profit Margin | 0.07 | 0.07 | |
Net Profit Margin | 0.04 | 0.03 | |
Gross Profit Margin | 0.50 | 0.62 |
Current Pfizer Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pfizer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
38.67 | Buy | 25 | Odds |
Most Pfizer analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pfizer stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pfizer Inc, talking to its executives and customers, or listening to Pfizer conference calls.
Pfizer Stock Analysis Indicators
Pfizer Inc stock analysis indicators help investors evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pfizer shares will generate the highest return on investment. By understating and applying Pfizer stock analysis, traders can identify Pfizer position entry and exit signals to maximize returns.
Begin Period Cash Flow | 416 M | |
Long Term Debt | 60.5 B | |
Common Stock Shares Outstanding | 5.7 B | |
Total Stockholder Equity | 89 B | |
Tax Provision | -1.1 B | |
Quarterly Earnings Growth Y O Y | -0.764 | |
Property Plant And Equipment Net | 18.9 B | |
Cash And Short Term Investments | 12.7 B | |
Cash | 2.9 B | |
Accounts Payable | 6.7 B | |
Net Debt | 72.2 B | |
50 Day M A | 27.47 | |
Total Current Liabilities | 47.8 B | |
Other Operating Expenses | 54.3 B | |
Non Current Assets Total | 183.2 B | |
Forward Price Earnings | 12.837 | |
Common Stock Total Equity | 478 M | |
Non Currrent Assets Other | 9.1 B | |
Stock Based Compensation | 525 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Dividend Share 1.64 | Earnings Share 0.37 | Revenue Per Share 10.366 | Quarterly Revenue Growth (0.41) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.